Susan Secore

1.2k total citations
23 papers, 694 citations indexed

About

Susan Secore is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Susan Secore has authored 23 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 13 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Susan Secore's work include Clostridium difficile and Clostridium perfringens research (9 papers), Viral gastroenteritis research and epidemiology (8 papers) and Muscle Physiology and Disorders (5 papers). Susan Secore is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (9 papers), Viral gastroenteritis research and epidemiology (8 papers) and Muscle Physiology and Disorders (5 papers). Susan Secore collaborates with scholars based in United States, United Kingdom and Australia. Susan Secore's co-authors include Richard J. Bartlett, Joe N. Kornegay, Allen D. Roses, W.‐Y. Hung, Michael H. Herbstreith, Constantinos D. Constantinou, Stëvên D. Van Camp, Susan Kettle, Michael J. Dykstra and Nicholas Sharp and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Susan Secore

23 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Secore United States 13 431 270 148 139 103 23 694
Nicholas D. Gansemer United States 16 278 0.6× 109 0.4× 168 1.1× 72 0.5× 81 0.8× 28 954
Oleg Iartchouk United States 9 337 0.8× 352 1.3× 146 1.0× 123 0.9× 111 1.1× 10 840
Ekaterina Mokhonova United States 14 341 0.8× 95 0.4× 95 0.6× 26 0.2× 50 0.5× 21 547
Scott J. Hempson United States 11 529 1.2× 244 0.9× 600 4.1× 84 0.6× 65 0.6× 11 1.0k
Kohtaro Miyazawa Japan 16 393 0.9× 88 0.3× 42 0.3× 58 0.4× 76 0.7× 62 662
Lauren Brinster United States 14 258 0.6× 86 0.3× 58 0.4× 26 0.2× 83 0.8× 30 612
Antonio Mori Italy 13 171 0.4× 111 0.4× 125 0.8× 23 0.2× 73 0.7× 37 536
Gabriella Leung Canada 16 193 0.4× 61 0.2× 91 0.6× 85 0.6× 355 3.4× 20 772
Franck Amiot France 15 309 0.7× 204 0.8× 69 0.5× 30 0.2× 238 2.3× 18 777
Kevin Redding United States 12 316 0.7× 69 0.3× 75 0.5× 243 1.7× 326 3.2× 20 1.2k

Countries citing papers authored by Susan Secore

Since Specialization
Citations

This map shows the geographic impact of Susan Secore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Secore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Secore more than expected).

Fields of papers citing papers by Susan Secore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Secore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Secore. The network helps show where Susan Secore may publish in the future.

Co-authorship network of co-authors of Susan Secore

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Secore. A scholar is included among the top collaborators of Susan Secore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Secore. Susan Secore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sullivan, Nicole, et al.. (2023). Elucidating the Immunogenic Mechanisms of Merck’s Lipid Nanoparticle (LNP) Adjuvants. The Journal of Immunology. 210(Supplement_1). 159.18–159.18. 1 indexed citations
2.
Austin, Lauren A., Jeffrey S. Smith, Debbie Nahas, et al.. (2022). Split-Dose Administration Enhances Immune Responses Elicited by a mRNA/Lipid Nanoparticle Vaccine Expressing Respiratory Syncytial Virus F Protein. Molecular Pharmaceutics. 20(1). 279–289. 7 indexed citations
3.
Hernandez, Lorraine D., Heather K. Kroh, Edward J. Hsieh, et al.. (2017). Epitopes and Mechanism of Action of the Clostridium difficile Toxin A-Neutralizing Antibody Actoxumab. Journal of Molecular Biology. 429(7). 1030–1044. 33 indexed citations
4.
Karczewski, Jakub, Jean-Luc Bodmer, James C. Cook, et al.. (2016). Design and Purification of Subunit Vaccines for Prevention of Clostridium difficile Infection. Methods in molecular biology. 1403. 385–396. 1 indexed citations
5.
Wang, Su, Richard R. Rustandi, David S. Thiriot, et al.. (2015). Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination. Vaccine. 34(10). 1319–1323. 11 indexed citations
6.
Wang, Su, Susan Secore, David S. Thiriot, et al.. (2014). An in vitro culture model to study the dynamics of colonic microbiota in Syrian golden hamsters and their susceptibility to infection with Clostridium difficile. The ISME Journal. 9(2). 321–332. 17 indexed citations
7.
Xie, Jinfu, Melanie Horton, Julie Zorman, et al.. (2014). Development and Optimization of a High-Throughput Assay To Measure Neutralizing Antibodies against Clostridium difficile Binary Toxin. Clinical and Vaccine Immunology. 21(5). 689–697. 10 indexed citations
8.
Wang, Su, Richard R. Rustandi, Feng Wang, et al.. (2014). Detecting and preventing reversion to toxicity for a formaldehyde-treated C. difficile toxin B mutant. Vaccine. 33(1). 252–259. 12 indexed citations
9.
Orth, Peter, Li Xiao, Lorraine D. Hernandez, et al.. (2014). Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography. Journal of Biological Chemistry. 289(26). 18008–18021. 109 indexed citations
10.
Karczewski, Jakub, Julie Zorman, Su Wang, et al.. (2014). Development of a recombinant toxin fragment vaccine for Clostridium difficile infection. Vaccine. 32(24). 2812–2818. 21 indexed citations
11.
Xie, Jinfu, Julie Zorman, Melanie Horton, et al.. (2013). Development and Optimization of a Novel Assay To Measure Neutralizing Antibodies against Clostridium difficile Toxins. Clinical and Vaccine Immunology. 20(4). 517–525. 12 indexed citations
12.
Fan, Hongxia, Martha Brown, James C. Cook, et al.. (2008). Development and Characterization of Monoclonal Antibodies to Staphylococcus aureus Capsule Type 5. The FASEB Journal. 22(S2). 669–669. 1 indexed citations
13.
Bartlett, Richard J., et al.. (1998). Toward Engineering Skeletal Muscle to Release Peptide Hormone From the Human Pre-Proinsulin Gene. Transplantation Proceedings. 30(2). 451–451. 10 indexed citations
14.
Bartlett, Richard J., et al.. (1997). Toward the biologic release of human insulin from skeletal muscle. Transplantation Proceedings. 29(4). 2199–2200. 12 indexed citations
15.
Bartlett, Richard J., Susan Secore, Rita Bottino, et al.. (1997). Use of biolistic particle accelerator to introduce genes into isolated islets of langerhans. Transplantation Proceedings. 29(4). 2201–2202. 4 indexed citations
16.
Bartlett, Richard J., Nena J. Winand, Susan Secore, et al.. (1996). Mutation segregation and rapid carrier detection of X-linked muscular dystrophy in dogs. American Journal of Veterinary Research. 57(5). 650–654. 44 indexed citations
17.
18.
Sharp, Nicholas, Joe N. Kornegay, Stëvên D. Van Camp, et al.. (1992). An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics. 13(1). 115–121. 267 indexed citations
19.
Secore, Susan, A.P. Walker, Michael H. Herbstreith, et al.. (1991). A Stul polymorphism on chromosome 3p14.1 -14.2 (D3S622) defined by two polymorphic Stul sites 2.4 kb apart. Nucleic Acids Research. 19(22). 6349–6349. 1 indexed citations
20.
Walker, A.P., FS Collins, Teepu Siddique, et al.. (1990). D21S194, a jump clone from D21S16. Nucleic Acids Research. 18(7). 1931–1931. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas D. Gansemer Breakdown of academic impact, for papers by Oleg Iartchouk Breakdown of academic impact, for papers by Ekaterina Mokhonova Breakdown of academic impact, for papers by Scott J. Hempson Breakdown of academic impact, for papers by Kohtaro Miyazawa Breakdown of academic impact, for papers by Lauren Brinster Breakdown of academic impact, for papers by Antonio Mori Breakdown of academic impact, for papers by Gabriella Leung Breakdown of academic impact, for papers by Franck Amiot Breakdown of academic impact, for papers by Kevin Redding
Rankless by CCL
2026